Health Services Utilization and Cost of Retinitis Pigmentosa
Open Access
- 1 May 2012
- journal article
- socioeconomics and-health-services
- Published by American Medical Association (AMA) in American Journal of Ophthalmology
- Vol. 130 (5), 629-634
- https://doi.org/10.1001/archophthalmol.2011.2820
Abstract
Retinal dystrophies are characterized by degeneration of photoreceptor and retinal pigment epithelium cells and are the major cause of incurable hereditary blindness in the Western world.1 Retinitis pigmentosa (RP) is the most frequent cause of inherited visual impairment (VI), with a prevalence of 1:4000, and is estimated to affect 50 000 to 100 000 people in the United States and approximately 1.5 million people worldwide.2,3 Manifesting initially with a deficiency in night vision, the course of RP is characterized by deterioration of specialized light-absorbing cells in the retina, leading to progressive loss of peripheral and day vision and, over decades, in most cases, severe VI or blindness. Age at onset can vary from early childhood to adulthood, with photoreceptor degeneration often present several years before a patient reports visual symptoms.4 Approximately 45 causal genes have been identified in RP, and these account for two-thirds of cases. In general, RP is a progressive disease, with exponential decline in the visual field area of approximately 9% per year and in cone electroretinographic amplitude of 10% per year.3,5-9This publication has 34 references indexed in Scilit:
- Subretinal electronic chips allow blind patients to read letters and combine them to wordsProceedings. Biological sciences, 2010
- Current Concepts in the Treatment of Retinitis PigmentosaJournal of Ophthalmology, 2010
- Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapyProgress in Retinal and Eye Research, 2010
- Lighting a candle in the dark: advances in genetics and gene therapy of recessive retinal dystrophiesJCI Insight, 2010
- Feasibility Study of a Retinal Prosthesis: Spatial Vision With a 16-Electrode ImplantYearbook of Ophthalmology, 2010
- HumanRPE65Gene Therapy for Leber Congenital Amaurosis: Persistence of Early Visual Improvements and Safety at 1 YearHuman Gene Therapy, 2009
- Vision Improvement in Retinal Degeneration Patients by Implantation of Retina Together with Retinal Pigment EpitheliumAmerican Journal of Ophthalmology, 2008
- Long-term visual prognoses in patients with retinitis pigmentosa: The Ludwig von Sallmann lectureExperimental Eye Research, 2007
- Rate of Visual Field Loss in Retinitis PigmentosaOphthalmology, 1997
- Natural Course of Retinitis Pigmentosa Over a Three-Year IntervalAmerican Journal of Ophthalmology, 1985